SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.

Wilke AC, Doebele C, Zindel A, Lee KS, Rieke SA, Ceribelli M, Comoglio F, Phelan JD, Wang JQ, Pikman Y, Jahn D, Haupl B, Schneider C, Scheich S, Tosto FA, Bohnenberger H, Stauder P, Schnutgen F, Slabicki M, Coulibaly ZA, Wolf S, Bojarczuk K, Chapuy B, Brandts CH, Stroebel P, Lewis CA, Engelke M, Xu X, Kim H, Dang TH, Schmitz R, Hodson DJ, Stegmaier K, Urlaub H, Serve H, Schmitt CA, Kreuz F, Knittel G, Rabinowitz JD, Reinhardt HC, Vander Heiden MG, Thomas C, Staudt LM, Zenz T, Oellerich T
Blood. 2022 Jan 27;139(4):538-553. doi: 10.1182/blood.2021012081. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.